drugset / Trial / NCT03932578

Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS

NCT03932578

Phase 4 Completed 60 enrolled Mansoura University
RandomizedParallel-groupSingle-blindSupportive care

Summary

The aim of this study is to evaluate the prophylactic use of low dose atropine and comparing it to metoclopramide for reducing intraoperative nausea and vomiting during cesarean section under spinal anesthesia

Timeline

Start
2019-05-05
Primary completion
2019-08-28
Completion
2019-08-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 100 ug Intrathecal
Comparator Metoclopramide Small molecule 10 mg Intravenous

Indications

No indication recorded.